The selling is routine in scale and pattern relative to TEVA's $39.9B market cap. Per academic literature, insider cluster sales are not predictive of forward returns, especially when trending over multiple weeks. No action warranted. Monitor for any earnings or clinical/regulatory catalyst that could change the business outlook.
TEVA drugs
TEVA drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 19 $34.07entry
- T+1 · 6mo ago +0.64%α −0.40% · $34.29
- T+5 · 6mo ago +1.04%α −1.25% · $34.43
- T+20 · 5mo ago −3.40%α −5.67% · $32.91
- T+60 · 3mo ago +6.98%α +0.96% · $36.45
Price Chart
How similar events traded
Executive Summary
TEVA insiders sold $5.66M in stock on May 14, 2026, led by CFO Eliyahu Sharon Kalif ($5.46M). The sales occurred at ~$35.60, with no open-market purchases by any insider. Relative to TEVA's $39.9B market cap, the cluster represents ~0.014%, trivial in proportional terms. Previous 30-day insider activity shows a consistent selling pattern ($12.9M over 6 sales), suggesting this is routine portfolio diversification or liquidity-driven selling, not an informed bearish signal.
Key Financial Metrics
Key Facts
- CFO sold 153,251 shares for $5.46M; SVP Business Development sold 5,746 shares for $0.20M
- Total cluster value: $5.66M, representing approximately 0.014% of TEVA's $39.9B market cap
- No open-market purchases in the 7-day cluster window or in the prior 30 days (6 sales totaling $12.9M)
- Non-cash derivative exercises by Lippman (11,841 shares at $0) are tax/paper events with zero economic value
Financial Impact
$5.66M in insider sales, ~0.014% of market cap. Trivial relative to TEVA's size.
Risk Factors
- Persistent insider selling without purchases could erode management credibility if fundamentals deteriorate
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TEVA-1779134594069 |
Track record
61 reports on TEVA
6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $42.57 −1.37% settles Feb 12
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 Now $42.57 −2.47% settles Feb 10
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $42.57 −1.55% settles Feb 9
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
- Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $42.57 −0.09% settles Feb 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers